InvestorsHub Logo
Followers 12
Posts 890
Boards Moderated 0
Alias Born 06/17/2011

Re: sunstar post# 163113

Wednesday, 02/26/2014 3:34:57 PM

Wednesday, February 26, 2014 3:34:57 PM

Post# of 346050
Sunstar,
"If a combination of bavituximab and your company's anti-PD-1 or other immuno mAb, shows a 100% response rate, and a doubling or tripling of cancer survivors, maybe you want to make Peregrine an offer that won't be refused before another company does. What are prevalent cures in cancer worth to BPs?"
This is what I believe and am waiting for! You are right on!
AtonewithPPHM
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News